Key result
Aortic valve replacement for native active infective endocarditis achieves ~75% survival at 10 years.
Why the study?
The impact of acute surgery for native aortic valve endocarditis on long-term prognosis after surgery was analyzed to address outcomes and predictors of survival.
What is the long-term survival and operative mortality in patients undergoing aortic valve replacement for native active infective endocarditis?
Population
161 patients undergoing aortic valve replacement for native active aortic valve endocarditis from 1967 to 1995
Design
Cohort study
Follow-up
Up to 15 years
Authors
Loading...
Acute AVR for native aortic endocarditis may support durable survival in selected cases; leaves open optimal timing, valve selection, and modern adjuncts.
Cohort (n=161)
What is the long-term survival and operative mortality in patients undergoing aortic valve replacement for native active infective endocarditis?
Aortic valve replacement for native active infective endocarditis provides satisfactory long-term outcomes, with 75% survival at 10 years and 91% freedom from recurrent endocarditis.
Giulio Pompilio (1998) conducted a cohort in Native active aortic valve endocarditis (n=161). Aortic valve replacement was evaluated on Long-term survival at 10 years. Aortic valve replacement for native active infective endocarditis resulted in an operative mortality of 8% and long-term survival of 75% at 10 years and 58% at 15 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: